Sun Pharma Q3 Results: Profit jumps 11% YoY to Rs 2,059 crore, beats estimates

Sun Pharma Q3 Results: Profit jumps 11% YoY to Rs 2,059 crore, beats estimates

Drug major Sun Pharma on Monday reported a consolidated net profit of Rs 2,058.80 crore for the December quarter, up 11.13 per cent against a profit of Rs 1,852.48 crore in the same quarter last year.

The total revenue from operations came in at Rs 9,863.06 crore, up 11.61 per cent against Rs 8,836.78 crore in the corresponding quarter last year.

The company beat analysts' estimates as a poll by ET Now projected profit at Rs 1,720 crore and revenue at Rs 9,635 crore.

The board of Directors of the company also announced Rs 7 per share interim dividend. The record date for the same is February 10. The payment of the interim dividend would be made to the eligible shareholders on or before February 22, 2022, the company said.

Also Read : Sun Pharmaceutical: Buy, sell or hold? What should investors do after Q2 results?

Operating EBITDA margin of the company on a standalone basis came in at 17.12 per cent during Q3FY22. The same was 20.53 per cent in Q2FY22 and 20.43 per cent in Q3FY21.

The net profit margin was at 13.67 per cent in Q3FY22, against 19.53 per cent and 12.07 per cent, respectively.

The drugmaker  Sun Pharma said it is also replacing its Company Secretary and Compliance Officer. The Board approved the appointment of Anoop Deshpande, who will replace Sunil Ajmera. Ajmera is being reassigned to a different role in the company.

Comments

Popular posts from this blog

Stocks in today's news: Bharti Airtel, Tech Mahindra, HDFC Bank and others

LIC IPO : Dates, Issue Price, GMP, Subscription, Share Analysis and Allotment

Stocks that moved the most on February 25 : Gainers & Losers